# Jim O'Neill President of the [[Thiel Foundation]] and a key operational figure in the [[Peter Thiel]] network. O'Neill manages the foundation's portfolio of programs including [[Thiel Fellowship]], [[Breakout Labs]], and grants to [[MIRI]] and [[SENS Foundation]]. His trajectory from [[Silicon Valley]] venture capital into senior federal health roles makes him one of the clearest examples of the [[Revolving Door]] between the [[Tech Right]] and the [[Second Trump Administration]]. ## Background O'Neill is a [[Silicon Valley]] investor and executive who built his career at the intersection of [[Libertarianism]], technology, and biotech. Before leading the [[Thiel Foundation]], he worked in venture capital focused on life sciences and healthcare startups — a background that shaped his deep skepticism of the [[FDA]]'s drug approval process. He has publicly argued that the [[FDA]] should not require proof of efficacy before approving drugs, only proof of safety — a position rooted in the libertarian view that patients and physicians, not regulators, should decide which treatments are worth trying. This perspective aligns with the broader [[Deregulation]] agenda championed by the Thiel network and connects to the Right to Try movement, which sought to let terminally ill patients access experimental drugs outside the standard [[FDA]] approval pipeline. O'Neill's stance drew both praise from free-market health policy advocates and sharp criticism from public health experts who argued it would expose patients to ineffective or harmful treatments. ## Thiel Foundation Leadership As president and CEO of the [[Thiel Foundation]], O'Neill oversaw the foundation's signature programs. The [[Thiel Fellowship]] pays young entrepreneurs to skip college and build companies — a direct expression of [[Peter Thiel]]'s contrarian view that higher education is an overpriced credentialing bubble. [[Breakout Labs]] funds early-stage scientific research too risky for traditional venture capital, with grants going to biotech, materials science, and energy startups. The foundation also channels philanthropic dollars to [[MIRI]] (the Machine Intelligence Research Institute, focused on AI safety) and [[SENS Foundation]] (focused on anti-aging and longevity research). Through this portfolio, O'Neill functioned as Thiel's chief operating lieutenant on the philanthropic side, while [[Peter Thiel]] concentrated on [[Founders Fund]] investments and political activity. The foundation's programs feed talent and ideas into the broader ecosystem of Thiel-backed companies including [[Palantir]] and [[Anduril]], creating a pipeline from academic disruption to defense tech. ## First Trump Administration During the first [[Trump Administration]], O'Neill served as Principal Associate Deputy Secretary at [[HHS]] (Department of Health and Human Services), where he led reforms at the [[FDA]] focused on food safety regulations and implementation of the FDA Amendments Act. His appointment was itself a signal of the Thiel network's reach into health policy — O'Neill had no traditional public health background, but brought the techno-libertarian conviction that [[Regulatory Capture]] and bureaucratic caution were costing lives by slowing innovation. He was reportedly considered for [[FDA]] commissioner during this period, a prospect that drew intense controversy given his views on efficacy requirements. ## Second Trump Administration In the [[Second Trump Administration]], O'Neill's role expanded dramatically. In November 2024, [[Donald Trump]] nominated him as Deputy Secretary of [[HHS]], serving under [[Robert F. Kennedy Jr]]. The Senate confirmed him in a 52–43 vote on June 5, 2025, and he assumed office four days later. The O'Neill-Kennedy pairing at [[HHS]] represented a convergence of two distinct anti-establishment currents: Kennedy's vaccine skepticism and natural-health populism, and O'Neill's [[Silicon Valley]] techno-[[Libertarianism]] and [[Deregulation]] philosophy. Both shared deep distrust of the pharmaceutical regulatory apparatus, though they arrived at that skepticism from different ideological starting points. In August 2025, O'Neill was concurrently appointed acting director of the [[CDC]], adding the nation's public health surveillance agency to his portfolio. By February 2026, he departed both [[HHS]] roles, and in March 2026 was nominated to direct the National Science Foundation — a move that extended [[Silicon Valley]] influence from health policy into federal science funding. ## Ideological Significance O'Neill embodies several patterns tracked in this KB. His career arc is a textbook [[Revolving Door]] case: from [[Silicon Valley]] venture capital to federal health agencies and back, carrying the [[Deregulation]] agenda of the Thiel network into institutions built on regulatory caution. His positions on drug approval sit within a broader [[Libertarianism]] framework that views the [[FDA]] and similar bodies as obstacles to innovation and individual choice — a view with deep roots in the [[Cato Institute]] and the free-market policy ecosystem. His rise also illustrates the [[Tech Oligarchy]] pattern: unelected technologists leveraging political donations and network connections to gain authority over public institutions whose missions they fundamentally question. The [[PayPal Mafia]] network that connects Thiel, O'Neill, [[Palmer Luckey]], and others now spans defense contracting ([[Palantir]], [[Anduril]]), health regulation ([[HHS]], [[FDA]], [[CDC]]), and science policy — a scope of influence that would have been difficult to imagine when the network began as a cluster of early internet entrepreneurs. ## Network Role O'Neill serves as one of [[Peter Thiel]]'s most trusted lieutenants, managing the philanthropic and talent-pipeline arm while Thiel focuses on investment ([[Founders Fund]]) and political activity. His role connects the [[Thiel Foundation]]'s programs to the broader defense tech and political ecosystem — a position that makes him less publicly visible than Thiel but arguably more operationally consequential in translating the network's ideology into institutional reality. ## See Also - [[Peter Thiel]] — patron and network center - [[Revolving Door]] — the pattern his career exemplifies - [[Founders Fund]] — Thiel's venture capital arm - [[Deregulation]] — the policy framework - [[Robert F. Kennedy Jr]] — his superior at HHS - [[Regulatory Capture]] — the critique animating his FDA stance - [[PayPal Mafia]] — the network genealogy - [[Silicon Valley]] — the ecosystem of origin